The influence of anesthetic drug strategy on the incidence of post-induction hypotension in elective, non-cardiac surgery – A prospective observational cohort study

J Clin AnesthPublished Prospective observational cohort study

Authors' conclusion

PIH was common in this patient cohort, regardless of the definition used. Two of the five examined modifiable factors were associated with PIH: remifentanil infusion was associated with an increased risk, and pre-emptive vasopressor use was associated with a decreased risk of PIH.

Study context

Population
Adult ASA I–IV patients undergoing elective non-cardiac surgery under general anesthesia (GA)720 analysed
Participants
760 patients
Exposure
Modifiable induction factors and post-induction hypotension (PIH)
Outcome
Incidence of PIH and associated modifiable factors
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

PIH, mean arterial pressure (MAP) <65 mmHg threshold
238 (33.1 %)
PIH, 30 % MAP decrease threshold
287 (39.9 %)
Remifentanil and PIH (MAP <65 mmHg): OR 1.88, 95 %CI 1.31-2.69
p < 0.001
Remifentanil and PIH (30 % MAP decrease): OR 1.66, 95 %CI 1.15-2.40
p = 0.007
Pre-emptive vasopressor (before or during first min of GA) and PIH (MAP <65 mmHg): OR 0.65, 95 %CI 0.45-0.95
p = 0.027
Pre-emptive vasopressor and PIH (30 % MAP decrease): OR 0.58, 95 %CI 0.40-0.84
p = 0.004

Observational data: associations, not effects.

Further findings

Propofol bolus dose by patient factors

Propofol bolus dose decreased with increasing age and ASA physical status

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

The influence of anesthetic drug strategy on the incidence of post-induction hypotension in elective, non-cardiac surgery – A prospective observational cohort study. J Clin Anesth. Published 28 October 2024. doi:10.1016/j.jclinane.2024.111671

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.